Obstetrics/Gynecology
RSSArticles
-
Is it Safe to Discharge Patients Without an Opioid Prescription After Gynecologic Surgery?
In this quality improvement initiative study, patients undergoing scheduled gynecologic abdominal surgery via both minimally invasive and open routes were able to be discharged safely without a prescription of opioids without significant increases in postoperative calls about pain or the need for filling opioid prescriptions after discharge.
-
Loop Electrosurgical Excision Procedure of the Cervix: Which Is the Best Method of Anesthesia?
In this randomized controlled trial comparing local anesthesia and general anesthesia for loop electrosurgical excision procedure of the cervix, there was no difference in patient satisfaction. However, women in the local anesthesia group had significantly smaller cone volumes and less blood loss than those in the general anesthesia group.
-
A Prospective Look at the Course of Untreated ADHD in Pregnancy Gains Attention
Twenty-five women with perinatal attention-deficit hyperactivity disorder were followed prospectively during pregnancy for changes in anxiety, depression, perceived stress, and functional impairment. Statistically significant differences in mood and functional impairment in the family domain were found in those who discontinued their psychostimulant.
-
Oral Progestogens for Prevention of Miscarriage
In this double-blind, randomized clinical trial, 406 pregnant women were randomized to dydrogesterone or placebo. There were no statistically significant differences in the primary outcome (miscarriage before 20 weeks of gestation; relative risk, 0.897; 95% confidence interval, 0.548-1.467; P = 0.772), which occurred in 12.8% and 14.3% in the dydrogesterone and placebo arms, respectively. The use of dydrogesterone in women with threatened miscarriage for the prevention of early pregnancy loss in the first trimester failed to decrease the miscarriage rate or increase the live birth rate.
-
Is HPV Testing Superior to Pap Testing Alone in Women at Risk of Cervical Cancer?
In this registry-based screening study of women in Catalonia, Spain, a negative human papillomavirus (HPV) and cytology co-test at baseline was associated with a cumulative incidence of cervical precancer of 0.4% at five years and 1.3% at nine years, compared to 27% among women with abnormal HPV testing at baseline.
-
Pregnancy After Treatment for Pelvic Floor Disorders
This consensus document was developed as a reference for physicians caring for and advising women in pregnancy following prior surgical treatment for pelvic floor disorders.
-
The Pregnancy Perspective: What Has COVID-19 Affected?
In this cross-sectional descriptive study, women using the Ovia pregnancy app expressed receiving adequately safe maternal care during the COVID-19 pandemic, but voiced concerns related to obtaining infant supplies and prenatal education.
-
New Guidelines Reinforce Need for Change in Cervical Cancer Screening Practice
Screening standards for cervical cancer have changed over the past two decades, including several updates since the first consensus guidelines, published in 2001 by the American Society of Colposcopy and Cervical Pathology. The 2020 revision is based on data showing that patients’ risk of developing cervical precancer or cancer can be estimated using screening test results, biopsy results, and consideration of personal patient factors.
-
Educational Sessions for Women with Opioid Use Disorder Improve Engagement
A Maine family planning clinic launched a program to reach women who experience barriers to reproductive healthcare, counseling, and testing for sexually transmitted infections. The program focused on outreach, sending an educator to various locations and providing an educational session for women who are especially vulnerable, including those who use opioids.
-
Study: Risk Assessment for Contraceptives Is Influenced by Cultural Biases
Cultural assumptions create unbalanced risk assessment when the medical community weighs the risks and benefits of common contraceptive methods, the authors of a recent study concluded. Researchers studied contraception risks and assessed how these risks were prioritized in reproductive health providers’ understanding of contraceptives and their potential side effects.